Sodium-glucose cotransporter-2 inhibitors reduce cardiovascular outcome and improve health status in Heart failure with preserved ejection fraction: an updated systematic review and meta-analysis

Abstract

Review question / Objective: Do SGLT2 inhibitors reduce cardiovascular outcomes and improve health status in patients with heart failure with preserved ejection fraction? INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols INPLASY PROTOCOL Sodium-glucose cotransporter-2 inhibitors reduce cardiovascular outcome and improve health status in Heart failure with preserved ejection fraction: an updated systematic review and meta-analysis Treewaree, S 1 ; Kulthamrongsri, N 2 ; Owattanapanich, W 3 ; Krittayaphong, R 4 . To cite: Treewaree et al. Sodium-glucose cotransporter-2 inhibitors reduce cardiovascular outcome and improve health status in Heart failure with preserved ejection fraction: an updated systematic review and meta-analysis. Inplasy protocol 202290023.